DREXEL MORGAN & CO. – Novartis AG Transaction History
DREXEL MORGAN & CO. portfolio value:
$739,000
portfolio value
DREXEL MORGAN & CO. quarter portfolio value change:
-10.08%
quarter
Novartis AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -83K | $76.01 | 9.72K | |
| Q2 2022 | share | 0.00% | 0 shares | -31K | $84.53 | 9.72K | |
| Q1 2022 | share | 0.00% | 0 shares | 3K | $87.75 | 9.72K | |
| Q4 2021 | share | 0.00% | 0 shares | 55K | $87.46 | 9.72K | |
| Q3 2021 | share | 0.00% | 0 shares | -92K | $81.78 | 9.72K | |
| Q2 2021 | share | 0.00% | 0 shares | 56K | $91.24 | 9.72K | |
| Q1 2021 | share | 0.00% | 0 shares | -87K | $85.48 | 9.72K | |
| Q4 2020 | share | 0.00% | 0 shares | 73K | $90.76 | 9.72K | |
| Q3 2020 | share | 0.00% | 0 shares | -4K | $83.58 | 9.72K | |
| Q2 2020 | share | 0.00% | 0 shares | 48K | $83.94 | 9.72K | |
| Q1 2020 | share | Increase | 0.00% | 9.72K shares | 801K | $79.24 | 9.72K |
| Q4 2016 | share | Decrease | -100.00% | -8.52K shares | -673K | $60.96 | 0 |
| Q3 2016 | share | 0.00% | 0 shares | -30K | $66.08 | 8.52K | |
| Q2 2016 | share | Increase | +0.50% | 42 shares | 89K | $69.05 | 8.52K |
| Q1 2016 | share | Decrease | -9.29% | -868 shares | -190K | $60.62 | 8.47K |